- Home
- MTNB vs ATCH Comparison
MTNB vs ATCH Comparison
Compare MTNB & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- ATCH
- Stock Information
- Founded
- MTNB 2013
- ATCH 2022
- Country
- MTNB United States
- ATCH United States
- Employees
- MTNB N/A
- ATCH N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- MTNB Health Care
- ATCH
- Exchange
- MTNB Nasdaq
- ATCH Nasdaq
- Market Cap
- MTNB 3.6M
- ATCH 3.0M
- IPO Year
- MTNB N/A
- ATCH N/A
- Fundamental
- Price
- MTNB $0.94
- ATCH $0.19
- Analyst Decision
- MTNB Hold
- ATCH
- Analyst Count
- MTNB 1
- ATCH 0
- Target Price
- MTNB N/A
- ATCH N/A
- AVG Volume (30 Days)
- MTNB 376.6K
- ATCH 2.4M
- Earning Date
- MTNB 08-13-2025
- ATCH 05-16-2025
- Dividend Yield
- MTNB N/A
- ATCH N/A
- EPS Growth
- MTNB N/A
- ATCH N/A
- EPS
- MTNB N/A
- ATCH 2.67
- Revenue
- MTNB N/A
- ATCH N/A
- Revenue This Year
- MTNB N/A
- ATCH N/A
- Revenue Next Year
- MTNB N/A
- ATCH N/A
- P/E Ratio
- MTNB N/A
- ATCH $0.07
- Revenue Growth
- MTNB N/A
- ATCH N/A
- 52 Week Low
- MTNB $0.47
- ATCH $0.18
- 52 Week High
- MTNB $9.60
- ATCH $66.00
- Technical
- Relative Strength Index (RSI)
- MTNB 56.79
- ATCH 37.27
- Support Level
- MTNB $0.88
- ATCH $0.18
- Resistance Level
- MTNB $1.04
- ATCH $0.20
- Average True Range (ATR)
- MTNB 0.09
- ATCH 0.01
- MACD
- MTNB -0.01
- ATCH 0.01
- Stochastic Oscillator
- MTNB 30.17
- ATCH 32.50
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.